| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,063,000 | 1,857,000 | 1,943,000 | 2,502,000 | | Cost of Revenue | 200,000 | 1,186,000 | 159,000 | 3,917,000 | | | Gross Profit | 1,863,000 | 671,000 | 1,784,000 | (1,415,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,091,000 | (4,000) | 1,194,000 | (2,293,000) | | Non Recurring |
-
|
-
|
-
| (141,000) | | Others | 210,000 | 207,000 | 207,000 | 206,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 562,000 | 468,000 | 383,000 | 813,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 37,000 | 36,000 | 17,000 | (11,000) | | Earnings Before Interest And Taxes | 599,000 | 504,000 | 400,000 | 831,000 | | Interest Expense | 118,000 | 113,000 | 117,000 | 112,000 | | Income Before Tax | 481,000 | 391,000 | 283,000 | 719,000 | | Income Tax Expense | 178,000 | 144,000 | 106,000 | 267,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 303,000 | 247,000 | 177,000 | 452,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 303,000 | 247,000 | 177,000 | 452,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $303,000 | $247,000 | $177,000 | $452,000 |
|
0.22% Nasdaq 0.00%
Income Statement
